Jacobio Pharmaceuticals Group Co., Ltd. 1167.HK Stock
Jacobio Pharmaceuticals Group Co., Ltd. Price Chart
Jacobio Pharmaceuticals Group Co., Ltd. 1167.HK Financial and Trading Overview
Contents
Jacobio Pharmaceuticals Group Co., Ltd. stock price | 1.58 HKD |
Previous Close | 6.45 HKD |
Open | 6.59 HKD |
Bid | 6.14 HKD x N/A |
Ask | 6.15 HKD x N/A |
Day's Range | 6.11 - 7.04 HKD |
52 Week Range | 3.3 - 10.48 HKD |
Volume | 10.63M HKD |
Avg. Volume | 3.08M HKD |
Market Cap | 4.88B HKD |
Beta (5Y Monthly) | 0.93775 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5 HKD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.79 HKD |
1167.HK Valuation Measures
Enterprise Value | 3.83B HKD |
Trailing P/E | N/A |
Forward P/E | -12.812501 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 50.97243 |
Price/Book (mrq) | 3.7003613 |
Enterprise Value/Revenue | 39.95 |
Enterprise Value/EBITDA | -8.075 |
Trading Information
Jacobio Pharmaceuticals Group Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.93775 |
52-Week Change | -5.14% |
S&P500 52-Week Change | 20.43% |
52 Week High | 10.48 HKD |
52 Week Low | 3.3 HKD |
50-Day Moving Average | 6.82 HKD |
200-Day Moving Average | 6.09 HKD |
1167.HK Share Statistics
Avg. Volume (3 month) | 3.08M HKD |
Avg. Daily Volume (10-Days) | 2.22M HKD |
Shares Outstanding | 793.56M |
Float | 287.12M |
Short Ratio | N/A |
% Held by Insiders | 43.74% |
% Held by Institutions | 28.98% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -502.29% |
Gross Margin | 13.19% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -18.23% |
Return on Equity (ttm) | -25.47% |
Income Statement
Revenue (ttm) | 95.75M HKD |
Revenue Per Share (ttm) | 0.13 HKD |
Quarterly Revenue Growth (yoy) | -56.79% |
Gross Profit (ttm) | N/A |
EBITDA | -473712000 HKD |
Net Income Avi to Common (ttm) | -371860992 HKD |
Diluted EPS (ttm) | -0.63 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.3B HKD |
Total Cash Per Share (mrq) | 1.68 HKD |
Total Debt (mrq) | 147.79M HKD |
Total Debt/Equity (mrq) | 11.52 HKD |
Current Ratio (mrq) | 8.59 |
Book Value Per Share (mrq) | 1.662 |
Cash Flow Statement
Operating Cash Flow (ttm) | -292417984 HKD |
Levered Free Cash Flow (ttm) | -158824880 HKD |
Profile of Jacobio Pharmaceuticals Group Co., Ltd.
Country | Hong Kong |
State | N/A |
City | Beijing |
Address | Building F2 |
ZIP | N/A |
Phone | 86 10 5631 5466 |
Website | https://www.jacobiopharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 303 |
Jacobio Pharmaceuticals Group Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-(L)1 resistant cancer; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. The company was founded in 2015 and is headquartered in Beijing, China.
Q&A For Jacobio Pharmaceuticals Group Co., Ltd. Stock
What is a current 1167.HK stock price?
Jacobio Pharmaceuticals Group Co., Ltd. 1167.HK stock price today per share is 1.58 HKD.
How to purchase Jacobio Pharmaceuticals Group Co., Ltd. stock?
You can buy 1167.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jacobio Pharmaceuticals Group Co., Ltd.?
The stock symbol or ticker of Jacobio Pharmaceuticals Group Co., Ltd. is 1167.HK.
Which industry does the Jacobio Pharmaceuticals Group Co., Ltd. company belong to?
The Jacobio Pharmaceuticals Group Co., Ltd. industry is Biotechnology.
How many shares does Jacobio Pharmaceuticals Group Co., Ltd. have in circulation?
The max supply of Jacobio Pharmaceuticals Group Co., Ltd. shares is 791.76M.
What is Jacobio Pharmaceuticals Group Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Jacobio Pharmaceuticals Group Co., Ltd. PE Ratio is now.
What was Jacobio Pharmaceuticals Group Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Jacobio Pharmaceuticals Group Co., Ltd. EPS is -0.5 HKD over the trailing 12 months.
Which sector does the Jacobio Pharmaceuticals Group Co., Ltd. company belong to?
The Jacobio Pharmaceuticals Group Co., Ltd. sector is Healthcare.
Jacobio Pharmaceuticals Group Co., Ltd. 1167.HK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}